Your browser doesn't support javascript.
loading
Diagnostic factors for recurrent pregnancy loss: an expanded workup.
Ticconi, Carlo; Nicastri, Elena; D'Ippolito, Silvia; Chiaramonte, Carlo; Pietropolli, Adalgisa; Scambia, Giovanni; Di Simone, Nicoletta.
Afiliação
  • Ticconi C; Department of Surgical Sciences, Section of Gynecology and Obstetrics, University Tor Vergata, Rome, Italy. ticconi@med.uniroma2.it.
  • Nicastri E; Department of Surgical Sciences, Section of Gynecology and Obstetrics, University Tor Vergata, Rome, Italy.
  • D'Ippolito S; U.O.C. di Ostetricia e Patologia Ostetrica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Chiaramonte C; Istituto di Clinica Ostetrica e Ginecologica, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Pietropolli A; Department of Biomedicine and Prevention, University Tor Vergata, Viale Oxford 81, 00133, Rome, Italy.
  • Scambia G; Department of Surgical Sciences, Section of Gynecology and Obstetrics, University Tor Vergata, Rome, Italy.
  • Di Simone N; Istituto di Clinica Ostetrica e Ginecologica, Università Cattolica del Sacro Cuore, Rome, Italy.
Arch Gynecol Obstet ; 308(1): 127-142, 2023 07.
Article em En | MEDLINE | ID: mdl-36964323
ABSTRACT

PURPOSE:

There is limited information on the risk factors for recurrent pregnancy loss (RPL).

METHODS:

In this study, a patient-based approach was used to investigate the possible involvement and relative relevance of a large number of diagnostic factors in 843 women with RPL who underwent an extensive diagnostic workup including 44 diagnostic factors divided into 7 major categories.

RESULTS:

The rates of abnormalities found were (1) genital infections 11.74%; (2) uterine anatomic defects 23.72%; (3) endocrine disorders 29.42%; (4) thrombophilias 62%; (5) autoimmune abnormalities 39.2%; (6) parental karyotype abnormalities 2.25%; (7) clinical factors 87.78%. Six hundred and fifty-nine out of eight hundred and forty-three women (78.17%) had more than one abnormality. The mean number of pregnancy losses increased by increasing the number of the abnormalities found (r = 0.86949, P < 0.02). The factors associated with the highest mean number of pregnancy losses were cervical isthmic incompetence, anti-beta-2-glycoprotein-1 antibodies, unicornuate uterus, anti-prothrombin A antibodies, protein C deficiency, and lupus anticoagulant. The majority of the considered abnormalities had similar, non-significant prevalence between women with 2 versus ≥ 3 pregnancy losses with the exception of age ≥ 35 years and MTHFR A1298C heterozygote mutation. No difference was found between women with primary and secondary RPL stratified according to the number of abnormalities detected (Chi-square 8.55, P = 0.07). In these women, the only factors found to be present with statistically different rates were age ≥ 35 years, cigarette smoking, and genital infection by Ureaplasma.

CONCLUSION:

A patient-based diagnostic approach in women with RPL could be clinically useful and could represent a basis for future research.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aborto Habitual / Aborto Induzido / Síndrome Antifosfolipídica Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Arch Gynecol Obstet Assunto da revista: GINECOLOGIA / OBSTETRICIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aborto Habitual / Aborto Induzido / Síndrome Antifosfolipídica Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Arch Gynecol Obstet Assunto da revista: GINECOLOGIA / OBSTETRICIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália